Avesthagen

Bangalore, India· Est. 2001

Avesthagen leverages population genetics and systems biology through The Avestagenome Project® to develop predictive diagnostics and personalized healthcare solutions.

avesthagen.com

Is this your company? Claim your profile to update info and connect with investors.

Claim profile

Private Company

Funding information not available

AI Company Overview

Avesthagen leverages population genetics and systems biology through The Avestagenome Project® to develop predictive diagnostics and personalized healthcare solutions.

OncologyInfectious Disease

Technology Platform

The Avestagenome Project®: a genetic, genealogical, and systems biology database of the Zoroastrian Parsi population used to identify disease biomarkers and enable predictive, preventive, and personalized healthcare.

Opportunities

Large opportunity in personalized medicine and preventive healthcare in India and globally; unique, proprietary population genetics database offers potential for diagnostic and therapeutic partnerships; growing consumer wellness market aligns with its nutrition division.

Risk Factors

High dependency on the niche Parsi cohort may limit generalizability of findings; capital-intensive long-term R&D with uncertain timelines to product commercialization; execution risk in managing diverse business segments from genomics to consumer goods.

Competitive Landscape

Competes with broad genomic and diagnostic companies (e.g., MedGenome, Strand Life Sciences in India) and global personal genomics firms, but is differentiated by its deep, systems-level study of a specific endogamous population and its convergence-of-technology business model.

More companies in India →